Skip to content

In-Home Technology for Dementia Caregivers

Developing and Evaluating In-Home Supportive Technology for Dementia Caregivers

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03828383
Enrollment
78
Registered
2019-02-04
Start date
2019-02-26
Completion date
2020-11-27
Last updated
2022-05-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer's Disease, Dementia, Frontotemporal Dementia

Keywords

Caregivers, Dementia, In-Home Assistive Technology

Brief summary

This study aims to develop and evaluate in-home assistive technology that is designed to alleviate anxiety, burden, and loneliness in spousal and familial caregivers of individuals with Alzheimer's disease and frontotemporal dementia.

Detailed description

This study aims to develop, refine, and evaluate a hardware/software system designed to integrate in-home sensors and devices, social connection, and Internet-of-Things (i.e., devices that can be controlled and communicated with via the internet) technologies to create a more supportive and safe home environment for caregivers and people with dementia. The system monitors troublesome behaviors in people with dementia (e.g., wandering), and targets mechanisms (e.g., worry, social isolation) thought to link behavioral symptoms in people with dementia with adverse caregiver outcomes (declines in health and well-being). The system is designed to minimize demands on caregivers' limited time and energy and to provide a platform for data collection that can be used by researchers and care professionals. Hypotheses: 1. Caregivers in the full operation condition will have fewer negative effects of caregiving (lower burden, higher mental and physical health, higher well-being) than those in the limited home safety condition. 2. Greater use of the social networking features of the system will be associated with fewer caregiver depressive symptoms. 3. Greater utilization of the home safety features of the system will be associated with fewer caregiver anxiety symptoms.

Interventions

DEVICEIn-home technology

Intelligent bots monitor the in-home sensors, learn typical patterns, and provide caregivers with text messages via cell phone and alerts via the tablet when worrisome behaviors occur. Social contact is encouraged using a trusted circle of friends and family who are encouraged to stay in contact and share photos and videos with the caregiver and person with dementia via the digital display.

Intelligent bot monitors the in-home water leak sensor and provide caregivers with text messages via cell phone and alerts via the tablet when worrisome conditions occur.

Sponsors

University of California, San Francisco
CollaboratorOTHER
People Power Company
CollaboratorINDUSTRY
National Institute on Aging (NIA)
CollaboratorNIH
University of California, Berkeley
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Investigator)

Masking description

Identical system is installed in all homes regardless of treatment arm. The member of research team who does the installation will now know which treatment arm has been assigned. Initiating the features of the system appropriate to the assigned treatment arm is done remotely by a member of the People Power staff (who has no contact with the participants) following the installation.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Caregivers are fluent/literate in English * Caregivers currently reside with spouse/family member with dementia * Caregivers primarily use an iPhone * Caregiver has wireless internet in home

Exclusion criteria

* Caregivers providing care for individuals with known non-neurodegenerative conditions affecting behavior and cognition * Caregivers providing care for individuals with longstanding Axis I psychiatric disorder * Caregivers providing care for individuals with metabolic disorder or major organ dysfunction * Caregivers providing care for individuals with alcohol abuse or dependence (within 5 years of dementia onset) * Caregivers providing care for individuals with head trauma with loss of consciousness greater than 30 minutes * Caregivers providing care for individuals with contraindications to MRI imaging * Caregivers providing care for individuals with large confluent white matter lesions * Caregivers providing care for individuals with significant systemic medical illness * Caregivers providing care for individuals who use a medication likely to affect central nervous system functions adversely If you live in the San Francisco Bay Area, Las Vegas (Clark County), Orange County, Los Angeles County, or Oregon, you may complete the following screening questionnaire to determine your eligibility for participation: https://bit.ly/UCBDC Upon completion of the screening questionnaire, the UC Berkeley research team will follow up soon after by email or phone to confirm your eligibility status.

Design outcomes

Primary

MeasureTime frameDescription
Zarit Burden Interview-Short Form9 months after baselineQuestionnaire to measure caregiver burden (Zarit, Reever, & Bach-Peterson, 1980). 12 items are rated on 0-4 scale. Range: 0-48. No subscales. Higher scores represent worse outcomes.
Center for Epidemiological Studies Depression Scale (CES-D)9 months after baselineQuestionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.
Beck Anxiety Inventory (BAI)9 months after baselineQuestionnaire to measure anxiety (Beck, Epstein, Brown, & Steer, 1988). 20 items are rated on a 0-3 scale and summed (range= 0-60). Higher scores indicate worse outcomes. There are no subscales. A score greater than 36 is considered to be clinically significant.
Satisfaction With Life Scale9 months after baselineQuestionnaire measuring overall life satisfaction and well-being (Diener, Emmons, Larsen, & Griffin, 1985). 5 items scored on a 1-7 scale and summed (Range = 5-35). Lower scores indicate worse outcomes. A score of 20 is considered neutral with higher scores considered increasingly more satisfied and lower scores considered increasingly more dissatisfied.

Countries

United States

Participant flow

Pre-assignment details

Note that outcomes are only assessed regarding caregiver health and well-being. Patients did not provide any information; therefore, all information reported for demographics and measures is only regarding caregivers.

Participants by arm

ArmCount
In-Home Technology System
The full system (sensors for entry, activity, temperature, water leak; voice control; digital display; local router) will be installed in the homes of caregivers by a member of the research team (blind as to arm of the study). Monitoring of sensors, provision of warnings, messaging, and social networking features will be activated remotely for those participants who have been randomly assigned to this arm. Participation will extend over a nine month period with questionnaires (e.g., health and well-being) administered 4 times (at the time of installation and every 3 months thereafter). In-home technology: Intelligent bots monitor the in-home sensors, learn typical patterns, and provide caregivers with text messages via cell phone and alerts via the tablet when worrisome behaviors occur. Social contact is encouraged using a trusted circle of friends and family who are encouraged to stay in contact and share photos and videos with the caregiver and person with dementia via the digital display.
37
Limited In-Home Technology System
The full system (sensors for entry, activity, temperature, water leak; voice control; digital display; local router) will be installed in the homes of caregivers by a member of the research team (blind as to arm of the study). Monitoring of the water leak sensor and associated warnings will be activated remotely for those participants who have been randomly assigned to this arm. Participation will extend over a nine month period with questionnaires (e.g., health and well-being) administered 4 times (at the time of installation and every 3 months thereafter). Limited in-home technology: Intelligent bot monitors the in-home water leak sensor and provide caregivers with text messages via cell phone and alerts via the tablet when worrisome conditions occur.
32
Total69

Withdrawals & dropouts

PeriodReasonFG000FG001
Overall StudyLost to Follow-up32
Overall StudyWithdrawal by Subject45

Baseline characteristics

CharacteristicLimited In-Home Technology SystemTotalIn-Home Technology System
Age, Continuous65.91 years
STANDARD_DEVIATION 10.75
65.01 years
STANDARD_DEVIATION 11.63
63.38 years
STANDARD_DEVIATION 12.7
Race/Ethnicity, Customized
Black or African American
0 Participants5 Participants5 Participants
Race/Ethnicity, Customized
East Asian, South Asian, Southeast Asian, or Indian American
1 Participants3 Participants2 Participants
Race/Ethnicity, Customized
Latino or Hispanic American
2 Participants4 Participants2 Participants
Race/Ethnicity, Customized
Native Hawaiian or Pacific Islander
0 Participants1 Participants1 Participants
Race/Ethnicity, Customized
Non-Hispanic White or European American
26 Participants50 Participants24 Participants
Race/Ethnicity, Customized
Other
3 Participants6 Participants3 Participants
Sex: Female, Male
Female
27 Participants52 Participants25 Participants
Sex: Female, Male
Male
5 Participants17 Participants12 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 370 / 32
other
Total, other adverse events
0 / 370 / 32
serious
Total, serious adverse events
0 / 370 / 32

Outcome results

Primary

Beck Anxiety Inventory (BAI)

Questionnaire to measure anxiety (Beck, Epstein, Brown, & Steer, 1988). 20 items are rated on a 0-3 scale and summed (range= 0-60). Higher scores indicate worse outcomes. There are no subscales. A score greater than 36 is considered to be clinically significant.

Time frame: 9 months after baseline

Population: 78 individuals enrolled into the study, 9 individuals dropped out before completing the baseline measure, and another 9 dropped out before completing the 9-month assessment for a total 60 individuals for this analysis.

ArmMeasureValue (MEAN)Dispersion
In-Home Technology SystemBeck Anxiety Inventory (BAI)7.74 score on a scaleStandard Deviation 6.82
Limited In-Home Technology SystemBeck Anxiety Inventory (BAI)11.20 score on a scaleStandard Deviation 8.08
Primary

Center for Epidemiological Studies Depression Scale (CES-D)

Questionnaire to measure depression (Radloff, 1977). 20 items are rated on a 0-3 scale and summed (range = 0-60). There are no subscales. Higher scores represent worse outcomes. The clinical cut-off is usually set at a score of 16.

Time frame: 9 months after baseline

Population: 78 individuals enrolled into the study, 9 individuals dropped out before completing the baseline measure, and another 9 dropped out before completing the 9-month assessment for a total 60 individuals for this analysis.

ArmMeasureValue (MEAN)Dispersion
In-Home Technology SystemCenter for Epidemiological Studies Depression Scale (CES-D)19.21 score on a scaleStandard Deviation 12.03
Limited In-Home Technology SystemCenter for Epidemiological Studies Depression Scale (CES-D)19.30 score on a scaleStandard Deviation 12.37
Primary

Satisfaction With Life Scale

Questionnaire measuring overall life satisfaction and well-being (Diener, Emmons, Larsen, & Griffin, 1985). 5 items scored on a 1-7 scale and summed (Range = 5-35). Lower scores indicate worse outcomes. A score of 20 is considered neutral with higher scores considered increasingly more satisfied and lower scores considered increasingly more dissatisfied.

Time frame: 9 months after baseline

Population: 78 individuals enrolled into the study, 9 individuals dropped out before completing the baseline measure, and another 9 dropped out before completing the 9-month assessment for a total 60 individuals for this analysis.

ArmMeasureValue (MEAN)Dispersion
In-Home Technology SystemSatisfaction With Life Scale17.35 score on a scaleStandard Error 7.36
Limited In-Home Technology SystemSatisfaction With Life Scale19.00 score on a scaleStandard Error 6.14
Primary

Zarit Burden Interview-Short Form

Questionnaire to measure caregiver burden (Zarit, Reever, & Bach-Peterson, 1980). 12 items are rated on 0-4 scale. Range: 0-48. No subscales. Higher scores represent worse outcomes.

Time frame: 9 months after baseline

Population: 78 individuals enrolled into the study, 9 individuals dropped out before completing the baseline measure, and another 9 dropped out before completing the 9-month assessment for a total 60 individuals for this analysis.

ArmMeasureValue (MEAN)Dispersion
In-Home Technology SystemZarit Burden Interview-Short Form24.58 score on a scaleStandard Deviation 8.09
Limited In-Home Technology SystemZarit Burden Interview-Short Form25.59 score on a scaleStandard Deviation 8.44

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026